Dynamic contrast-enhanced breast MRI features correlate with invasive breast cancer angiogenesis
Open Access
- 16 April 2021
- journal article
- research article
- Published by Springer Nature in npj Breast Cancer
- Vol. 7 (1) , 1-9
Abstract
Angiogenesis is a critical component of breast cancer development, and identification of imaging-based angiogenesis assays has prognostic and treatment implications. We evaluated the association of semi-quantitative kinetic and radiomic breast cancer features on dynamic contrast-enhanced (DCE)-MRI with microvessel density (MVD), a marker for angiogenesis. Invasive breast cancer kinetic features (initial peak percent enhancement [PE], signal enhancement ratio [SER], functional tumor volume [FTV], and washout fraction [WF]), radiomics features (108 total features reflecting tumor morphology, signal intensity, and texture), and MVD (by histologic CD31 immunostaining) were measured in 27 patients (1/2016–7/2017). Lesions with high MVD levels demonstrated higher peak SER than lesions with low MVD (mean: 1.94 vs. 1.61, area under the receiver operating characteristic curve [AUC] = 0.79, p = 0.009) and higher WF (mean: 50.6% vs. 22.5%, AUC = 0.87, p = 0.001). Several radiomics texture features were also promising for predicting increased MVD (maximum AUC = 0.84, p = 0.002). Our study suggests DCE-MRI can non-invasively assess breast cancer angiogenesis, which could stratify biology and optimize treatments.Keywords
This publication has 59 references indexed in Scilit:
- Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trialThe Lancet Oncology, 2013
- Bevacizumab Added to Neoadjuvant Chemotherapy for Breast CancerNew England Journal of Medicine, 2012
- Vascular proliferation is a prognostic factor in breast cancerBreast Cancer Research and Treatment, 2011
- Basic and Therapeutic Aspects of AngiogenesisCell, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Association between serial dynamic contrast‐enhanced MRI and dynamic 18F‐FDG PET measures in patients undergoing neoadjuvant chemotherapy for locally advanced breast cancerJournal of Magnetic Resonance Imaging, 2010
- Angiogenesis and Breast CancerJournal of Oncology, 2010
- The Importance of Tumor AngiogenesisAmerican Journal of Clinical Pathology, 2004
- The Importance of Tumor Angiogenesis: The Evidence Continues to GrowAmerican Journal of Clinical Pathology, 2004
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971